897086-96-3 Usage
Uses
Used in Pharmaceutical Industry:
HDH-PHARMA 23781 is used as a therapeutic agent for treating conditions such as acromegaly and pituitary adenomas, which are related to abnormal growth hormone secretion. Its application is based on its ability to effectively inhibit the stimulation of growth hormone release induced by ghrelin, a natural ligand for GHS-R1a.
Used in Research and Development:
HDH-PHARMA 23781 is used as a research compound for studying the effects of growth hormone secretagogue receptor antagonists on growth hormone release and related disorders. This helps in understanding the underlying mechanisms of growth hormone dysregulation and the potential of HDH-PHARMA 23781 as a pharmaceutical agent for addressing these disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 897086-96-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,7,0,8 and 6 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 897086-96:
(8*8)+(7*9)+(6*7)+(5*0)+(4*8)+(3*6)+(2*9)+(1*6)=243
243 % 10 = 3
So 897086-96-3 is a valid CAS Registry Number.
897086-96-3Relevant academic research and scientific papers
UREA/CARBAMATES FAAH MAGL OR DUAL FAAH/MAGL INHIBITORS AND USES THEREOF
-
Paragraph 0156, (2016/02/18)
Disclosed are compounds that may be used to inhibit the action of fatty acid amide hydrolase (FAAH), monoacylglycerol lipase (MAGL) or dual FAAH/MAGL.
